BTIG analyst Mark Massaro maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell, adjusts target to $7 from $0.2 (1-40 Reverse Stock Split).
BTIG Maintains Sell on Ginkgo Bioworks Holdings, Adjusts Price Target To $7 (1-40 Reverse Stock Split)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.